« Back
Home /
Serdemetan

Serdemetan

Item no.	TMO-T2243-100mg
Manufacturer	TargetMol
CASRN	881202-45-5
Amount	100 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 25 mg 2 mg 500 mg 50 mg 5 mg
Category	Oncology Reagents & Chemicals Molecules By Organ Lung Cancer
Type	Molecules
Specific against	other
Citations	1. Kojima K, et al. Mol Y Ther. 2010, 9(9), 2545-2557.2. Yuan Y, et al. J Hematol Oncol. 2011, 4:16.
Smiles	C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	JNJ-26854165
Shipping Condition	Cool pack
Available
Manufacturer - Targets	p53\|\|\|Mdm2\|\|\|Apoptosis\|\|\|E1/E2/E3 Enzyme
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	328.41
Description	Serdemetan (JNJ-26854165) is an orally bioavailable HDM2 antagonist with potential antineoplastic activity.
Pathways	Apoptosis\|\|\|Ubiquitination

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T2243-100mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question